References
- Caro J. J., Ward A., Green T. C., Huybrechts K., Arana A., et al. Impact of thalassemia major on patients and their family. Acta Haematologica 2002; 107((3))150–157
- Jaffe J. H., Anthony J. C. Substance‐related disorder: Introduction and overview. Comprehensive text book of psychiatry, B. J Sadock, V. A Sadock. Lippincot, Williams and Wilkins, Philadelphia, PA 1995; 1137–1328
- Kaplan H. J., Sadock B. J. BBJA synopsys of psychiatry. Williams and Wilkins, Baltimore, MD 1998; 1257–1260, (8th edn)
- Lanzkowsky P. Manual of pediatric hematology and oncology. Academic Press, San Diego, CA 2000; 182–193, (3rd edn)
- Olivieri N. F., Weatherall D. J. Pediatric hematology. Churchill Livingstone, London 2000; 307–327, (2nd edn)
- Olivieri N. F., Brittenham G. M. Iron‐chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739–761
- Quirolo K., Vichinisky E. Nelson text book of pediatrics. Saunders Co, Philadelphia, PA 2004; 1478–1487, (17th edn)
- Razaghi Omran M., Rahimi A., Moaser Afarin R., et al. Rapid situation assessment of substance use in Iran. Prevention assistance of Country Welfare Organization‐United Nations' substance control programme. 2002; 1: 50–110
- Telfer P., Constantinidou G., Andreou P., Christou S., et al. Quality of life in thalassemia. Annals of the New York Academy of Science 2005; 1054: 273–282